Peer-reviewedCC BYToxics
Synthetic Cannabinoids: Metabolism, Biomarkers of Exposure and Advanced Analytical Strategies in Forensic and Clinical Toxicology
- 1CQM—Centro de Química da Madeira, , Caminho da Penteada, 9020-105 Funchal, Portugal
- 2UCIBIO—Applied Molecular Biosciences Unit, Laboratory of Toxicology, Faculty of Pharmacy, , 4050-313 Porto, Portugal
- 3Centro de Tratamento de Adições, Departamento de Saúde Mental, Hospital dos Marmeleiros, Serviço Regional de Saúde da Região Autónoma da Madeira (SESARAM), EPE, Estrada dos Marmeleiros, 9054-535 Funchal, Portugal
Related
- The hidden effects of metabolism-disrupting agents on alcohol-related liver disease risk: an integrated epidemiological, machine learning, and network toxicology Analysis.
- Beyond Known PFAS: Emerging Analytical Strategies for Resolving the Hidden Fluorinated Chemical Space
- Tryptophan Metabolism in Pediatric Atopic Dermatitis: Shared Mechanisms, Age-Specific Biomarkers, and Emerging Therapies
- The Gut–Kidney Axis in Chronic Kidney Disease: Microbial Dysbiosis, Host–Microbial Metabolism, and Emerging Therapeutic Strategies
- Concordance Between Capillary Dried Plasma Spot and Venous Plasma Biomarkers in Traumatic Brain Injury: An Analytical Feasibility Pilot Study
BibTeX
@article{gomes2026synthetic,
title = {{Synthetic Cannabinoids: Metabolism, Biomarkers of Exposure and Advanced Analytical Strategies in Forensic and Clinical Toxicology}},
author = {Telma M. Gomes and Paula Guedes de Pinho and Ivone Nunes and José S. Câmara},
journal = {Toxics},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13709824},
note = {CC BY},
}
RIS
TY - JOUR
TI - Synthetic Cannabinoids: Metabolism, Biomarkers of Exposure and Advanced Analytical Strategies in Forensic and Clinical Toxicology
AU - Telma M. Gomes
AU - Paula Guedes de Pinho
AU - Ivone Nunes
AU - José S. Câmara
PY - 2026
DA - 2026/10/01
JO - Toxics
UR - https://europepmc.org/article/PMC/PMC13709824
SN - 2305-6304
ER -